Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (18497)	1/27/2000 1:18:00 AM
From: Ditchdigger	Respond to of 29382

Hi Sergio,,Amgen isn't a large holding of JAGLX(155,530 shares owned). I don't know the exact percentage(not one of the top ten)..It is shown in the Janus report as one of 13 companies in the medical/bio/generic group. The group as a whole makes up 26.5% of the total fund....The one stock in the fund that can move it one way or the other is QLT Photo Therapeutics..9.8% of the fund...DD PS: JAGLX closed up .35% yesterday,,very nice on a rough day.;^) PPS: Janus doesn't have a biotech fund that I'm aware of,,only the global life sciences fund,,which of course, does hold some biotechs